Home / News / FDA, DoD Sign MoU to Accelerate Availability of Medical Products for Military Servicemen

FDA, DoD Sign MoU to Accelerate Availability of Medical Products for Military Servicemen

The Food and Drug Administration and the Defense Department have formalized the framework of an earlier plan to accelerate the development and availability of emergency medical products for the U.S. military.

FDA said Friday it signed a memorandum of understanding with the DoD's Office of Health Affairs to commence with the program's implementation, as provided for under House Resolution 4374 that was passed in 2017.

The MoU authorizes the FDA and the Pentagon to work toward faster deployment of medical products meant to diagnose, treat or prevent life-threatening conditions affecting U.S. service members, including those caused by chemical, biological, radiological or nuclear agents.

"It's our honor and duty to support our military personnel by ensuring they have access to safe and effective medical products – especially products that meet the unique needs and settings in which soldiers may require medical treatment," said FDA Commissioner Scott Gottlieb.

 

Check Also

DARPA Launches Program Seeking High Performance Computing for Military Simulators

The Defense Advanced Research Projects Agency launched a new program to improve how virtual training environments replicate real-world interactions and host more complex systems. DARPA unveiled Monday that the Digital RF Battlespace Emulator program intends to build a new breed of High Performance Computing capable of supporting advanced radio frequency for simulators.